Clinical Trial Update: A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating the safety, pharmacokinetics and preliminary efficacy of TNP-2092 administered via intra-articular injection in participants with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periprosthetic Joint Infection

Drugs mentioned

• TNP-2092

Snippet

Sponsor: TenNor Therapeutics Inc. | Conditions: Periprosthetic Joint Infection (PJI) | Phase 1, Phase 2 | Status: RECRUITING